Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer
Research output: Contribution to journal › Journal article › Research › peer-review
The role of tissue inhibitor of metalloproteinases-1 (TIMP-1) in estrogen receptor (ER) positive breast cancer remains to be fully elucidated. We evaluated TIMP-1 as a prognostic marker in patients treated with adjuvant tamoxifen and investigated TIMP-1s association with Ki67 and ER/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2) profiles.
Original language | English |
---|---|
Journal | Acta Oncologica |
Volume | 52 |
Issue number | 1 |
Pages (from-to) | 82-90 |
Number of pages | 9 |
ISSN | 0284-186X |
DOIs | |
Publication status | Published - 2013 |
- Aged, Antineoplastic Agents, Hormonal, Breast Neoplasms, Cohort Studies, Female, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Kaplan-Meier Estimate, Ki-67 Antigen, Middle Aged, Multivariate Analysis, Prognosis, Receptor, erbB-2, Receptors, Estrogen, Receptors, Progesterone, Tamoxifen, Tissue Inhibitor of Metalloproteinase-1
Research areas
ID: 59304932